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Chemical space is enormously huge but not all of it is pertinent for the drug 
designing. Virtual screening methods act as knowledge-based filters to discover 
the coveted novel lead molecules possessing desired pharmacological 
properties. Support Vector Machines (SVM) is a reliable virtual screening tool 
for prioritizing molecules with the required biological activity and minimum 
toxicity. It has to its credit inherent advantages such as support for noisy data 
mainly coming from varied high-throughput biological assays, high sensitivity, 
specificity, prediction accuracy and reduction in false positives. SVM-based 
classification methods can efficiently discriminate inhibitors from non-
inhibitors, actives from inactives, toxic from non-toxic and promiscuous from 
non-promiscuous molecules. As the principles of drug design are also 
applicable for agrochemicals, SVM methods are being applied for virtual 
screening for pesticides too. The current review discusses the basic kernels and 
models used for binary discrimination and also features used for developing 
SVM-based scoring functions, which will enhance our understanding of 
molecular interactions. SVM modeling has also been compared by many 
researchers with other statistical methods such as Artificial Neural Networks, k-
nearest neighbour (kNN), decision trees, partial least squares, etc. Such studies 
have also been discussed in this review. Moreover, a case study involving the 
use of SVM method for screening molecules for cancer therapy has been 
carried out and the preliminary results presented here indicate that the SVM is 
an excellent classifier for screening the molecules.  
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1. INTRODUCTION  
 Virtual screening is a broad term encompassing various tools, techniques and methods to obtain the 
molecule with desired properties [1]. The vast amount of data being generated by the "omics" technologies and 
the computational possibility of generating innumerable compounds require a virtual screening (VS) tool 
capable of identifying different types of potential inhibitors from large compound libraries with high yields and 
low false-hit rates similar to high throughput screening (HTS). A right choice of the method depends upon the 
amount of available knowledge at hand. The target-based virtual screening methods such as docking and 
pharmacophore modeling are routinely used if we have well resolved X-ray crystallographic data available or a 
good homology model can be generated. In the absence of both, the ligand-based techniques that can be used 
include Quantitative Structure Activity Relationship (QSAR), pharmacophore searching, similarity searching, 
database screening etc.[2]. Recently, several machine learning methods have been reported; among them 
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Support Vector Machine (SVM) and its regression performing analogue namely Support Vector Regression 
(SVR) have emerged as the most powerful techniques in computational chemistry [3].  Support vector machines 
have been used on million dimensional data sets and in other cases with more than a million examples [4]. An 
SVM-based virtual screening method is a rapid computational tool for the prediction of potential lead molecules 
for any drug discovery program [5]. The SVM and SVR techniques have been extensively employed in 
bioinformatics and chemical engineering (see e.g. [6-12]). As compared to the SVM, its regression analogue 
SVR has been sparingly used in virtual screening efforts. Accordingly, this review mainly considers SVM as a 
powerful technique for speeding up virtual screening efforts. Although there exists a deficiency of 3D 
structural experimental data on known expressed proteins, the SVM models can be still employed as filters to 
obtain efficient lead molecules in virtual screening cycles. The SVM   builds predictive models for regression 
and classification of molecules thus offering medicinal chemists a rapid way to identify novel leads requiring 
least experimental efforts.  Its predictive ability is emphasized by the formalism's successful application to 
different test sets of diverse and various multi-targeted compounds. The SVM models generally give an 
estimated sensitivity of greater than 83% and specificity of greater than 99%, and thus have been used to screen 
millions of compounds in free and proprietary chemical databases [13]. They are capable of identifying novel 
inhibitors and distinguishing inhibitors from structurally similar non-inhibitors. In comparison with other virtual 
screening tools the SVM model is found to possess a broad applicability domain and a low false positive rate, 
which makes it suitable for the virtual screening of chemical libraries. SVM models exhibit good accuracy at 
cross-validation and independent testing.  The predictive ability of these models in virtual screening is evaluated 
by parameters such as the number of false positives, false negatives, true negatives and true positives, sensitivity 
and specificity, error rate and Mathews correlation coefficient (MCC), and finally experimental validation is 
conducted to substantiate model predictions. Target-based SVM models can correctly indicate interactions with 
residues as well as hydrogen bonding between the key residues which has a tremendous relevance for important 
substructures and functional groups that  are linked to the protein-ligand interactions for structure-activity 
relationship (SAR) studies.  Hence, these models consistently provide guidelines for enhancing activity in novel 
candidate molecules–the ultimate objective of drug designing. In this review, we analyze three major types of 
SVM-based virtual screening approaches as depicted in Figure 1. 
 
 
 
Fig. 1: SVM based major virtual screening methods 
 
 
1.1  SVM theory: An overview  
 The SVM is a statistical learning theory based nonlinear model developed by Vapnik et al. [3] that 
discriminates between data points of distinct classes (binary SVM) such that the margin between both the 
classes is maximized. This margin models the linear decision hyperplane. The basic idea of SVM is to map the 
training data nonlinearly into a higher dimensional feature space via a mapping function and construct a 
separating hyperplane with maximum margin there. This yields a nonlinear decision boundary in the input 
space. 
 
 
   45              ISSN: 2278-8115 
 
IJCB Vol. 1, No. 1, 2012, 43 – 55        http://www.ijcb.in 
 
 
 
 
 
 
 
 
 
 
 
 Figure 2: Mapping function  maps the training data nonlinearly into a higher dimensional feature 
 space wherein a separating hyperplane with maximum margin is constructed yielding a nonlinear 
 decision boundary in the input space. 
  
 The final position and orientation of the hyperplane are defined by a subset of training vectors, the so-
called support vectors. Usually, the SVM approaches are used in association with a radial basis function (RBF) 
as the kernel function although other kernel functions such as dot, polynomial, sigmoid, multi-quadratic, 
Gaussian combination etc. have also been explored.  
 SVMs use an implicit mapping,  , of the input data into a high-dimensional feature space defined by a 
kernel function, i.e., a function returning the inner product ( (x),  (x')) between the images of two data points 
x, x' in the feature space. The learning then takes place in the feature space, and the data points only appear 
inside dot products with other points [14]. This is often referred to as the “kernel trick” [15]. Owing to this trick, 
it becomes unnecessary to perform any computations in the high-dimensional feature space since all the 
requisite computations can be carried out directly in the input space. 
 
 
 
  
 
 
 
 
 Figure3 (a) A number of hyperplanes are possible to separate the two classes, (b) The SVM algorithm 
 constructs a hyperplane that maximizes separation between two classes.  
 
 As shown in Figure 3 an SVM classifier finds a hyper-plane that maximizes the separation between the 
two (or more) classes. The panel (a) in Figure 3 shows a number of hyper-planes that separate the data 
corresponding to a binary classification problem. However, there exists only one hyperplane that maximizes the 
separation. Locating such a maximum-margin hyperplane (MMH), as shown in the panel (b) of the Figure, 
results in a classifier possessing improved generalization capability owing to which the classifier can make 
correct predictions for new inputs. Correctly locating the MMH requires solving a quadratic optimisation 
problem with a single minimum. As a result, difficulties in locating an optimum solution that corresponds to the 
global or a deepest local minimum on the error surface (as in Artificial Neural Network training) are avoided in 
the SVM training.  A short summary of the commonly employed SVM training algorithm for correctly placing a 
large margin hyper-plane is given below [16]: 
 Given labeled  data pairs (x1, y1),…, (xi, yi) comprising multiple input vectors xi (i = 1,β, .., n) and the 
corresponding scalar outputs, yi ( i = 1, β,…, n) and a kernel, k, the SVM computes a function: 
 
 
     
  
 where coefficients i  (Lagrange multipliers) and b are found by solving the following 
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optimisation problem: 
Minimize          ni ijin ji ji Cssk 11, ),(               (2) 
subject to     iii xfy  1)(                                               (3) 
 
 where C refers to the regularization parameter, and  i  refers to the slack variables. Intuitively, the 
kernel function k computes similarity between two given examples. The most commonly employed kernel 
functions are: 
RBF kernels:               
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Polynomial kernels:     
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 The SVM finds a large margin separation between the training examples and previously unseen 
examples will often be close to the training examples. The large margin then ensures that these examples are 
correctly classified as well (high generalization ability). The SVM training algorithm constructs models that are 
adequately complex yet unlike artificial neural networks are simple enough to be analysed mathematically. 
SVM is capable of handling multiple continuous and also categorical variables.  
 
1.2 Ligand-based virtual screening using SVM  
 Since a very few protein crystal structures have been solved experimentally by an X-ray or an NMR 
technique, the ligand-based approaches serve as a valuable tool for virtual screening.  The ligand-based SVM 
approach can be used even in the absence of receptor information and a number of researchers have used it 
successfully to obtain inhibitors for a range of pharmacologically important targets. Commonly, two kernels are 
used in the ligand-based virtual screening viz. 2D Tanimoto kernel and 3D pharmacophore kernel. While a 
number of graph kernels are used in chemoinformatics, the Tanimoto kernel is the most commonly used one. If 
we consider feature map ɸd  and corresponding kernel kd then Tanimoto kernel ktd is defined as [17 ] ktd 
 
 
 
 
 where u and v  denote two molecules and d is an integer.  
 The initial reports on virtual screening used Binary Kernel Discrimination (BKD), a fingerprint based 
method based on Tanimoto concept of similarity as the machine learning approach. Willet et al. [18] performed 
a comparative study of virtual screening using binary kernel discrimination (BKD) with other ligand fingerprint 
based virtual screening chemoinformatics methods and found the BKD method to be much superior in drug and 
pesticide discovery  but lower in performance than the SVM. Byvatov  et al. [19] trained an SVM for the 
prediction of D3 and D2 receptor selective ligands. The hit compounds were synthesized and shown to possess 
nanomolar affinity. This approach was further refined by Chen et al. [20]  who observed the effect of noisy data 
on the model using MDDR database and also noticed  that its predictive ability depended on the number of  
false positives in the training set. Wilton et al. [21] obtained similar results in their work on pesticide data from 
Syngenta corporate database. Pharmacophores are important structural features present in a molecule which help 
in binding with a receptor thus giving rise to its biological activity. The pharmacophoric features are limited in 
number that mainly include  ring centroid, aromatic ring, hydrophobic regions, hydrogen bond acceptor, 
hydrogen bond donors, etc. An example of a three point pharmacophore is shown in Figure 4. 
 
Fig. 4: A three  point pharmacophore query and three interatomic distances 
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 Pharmacophores serve as very important parameters in virtual screening of chemical libraries. An SVM 
based pharmacophore modeling has been performed by using the pharmacophore kernel which is defined as 
follows [22]. 
For any pair of pharmacophores,  p = [(x1 l1), (x2 l2), (x3 l3)] and p′ = [ (x1′ l1′), (xβ′ lβ′), (xγ′ lγ′)]  
 
                              
 
 where ||•|| corresponds to the Euclidean distance, the index i+1 is taken as modulo 3, KFeat and KDist 
are the kernel functions introduced to compare pairs of labels of atoms and pairs of distances, Ki corresponds to 
the intrinsic similarity and KS corresponds to the spatial similarity of the pharmacophores.  Franke et al. [23]   
have demonstrated the effectiveness of this strategy by applying it for screening of COX-2 inhibitors. 
 Chen et al. [24] used Atom Pair (AP) structure and physicochemical (PC) descriptors of compounds to 
generate SVM-AP (support Vector Machine - Atom Pairs) and SVM-PC (Support Vector Machine Physico-
Chemical) models to develop "LigSeeSVM," a screening tool for ligand-based virtual screening, which was 
validated on five different datasets.  In another study [25], SVM modeling was performed to screen inhibitors 
for LCk1- a target implicated in the auto-immune diseases. The model had an estimated sensitivity of greater 
than 83% and specificity of greater than 99%, and it was used to screen 168014 compounds in the MDDR 
database and found to have a yield of 45.8% and a false positive rate of 0.52 %. Ma et al. [26] assessed the 
performance of SVM by using a sparse data set of active compounds for six target classes in the MDDR 
database namely muscarinic M1 receptor agonists, NMDA receptor antagonists, thrombin inhibitors, HIV 
protease inhibitors, cephalosporins, and renin inhibitors. They found the SVM method to be superior to 
Tanimoto coefficient based similarity search methods at giving low false hit rates. The predicted compounds 
were verified by a cellular activity assay proving SVM to be an efficient method. Jorrisen and Gilson [27] 
developed a modified version of SVM to not only classify molecular data but also enrichment of actives by 
using a novel method for identifying descriptors and cross-validating them as parameters in training the SVM. 
The results obtained were better than those based on fingerprints such as binary kernel discrimination. Han et al. 
[28] improved the performance of SVM for virtual screening of huge libraries by including a number of diverse 
non-actives in the training dataset. The hit rates and enrichment factors were found to increase dramatically for 
datasets of HIV protease inhibitors, DHFR inhibitors, dopamine antagonists and CNS active agents and were 
better than those based on the other ligand-based virtual screening methods. 
 
1.3 Sequence based virtual screening using SVM 
 In a recent report by Wang et al. [29], a novel SVM method using only sequence data of targets and 
information on 2D structures of small molecules was developed. This SVM model was based on 15,000 ligand 
protein interactions derived from 626 protein and 10,000 active compounds. The methodology was used for 
identifying nine active compounds for four targets viz., GRP40, SIRT1, p38, and GSK-γȕ and can also be 
extended to other proteins. 
 
1.4 Target-based virtual screening using SVM 
 Target-based virtual screening methods have recently been introduced compared to the conventional 
ligand based methods. The latter method has several drawbacks, the most important being the neglect of the 
receptor with no consideration to its flexibility and secondly a lack of adequate scoring functions. Currently, a 
number of research groups are focussing on the target-based SVM methods for success in virtual screening. Li 
et al. [30] have reported SVM-SP, an exclusive target based scoring function that yielded better enrichment than 
Glide docking score as evidenced by the ROC-AUC (Receiver Operating Curve - Area Under the Curve) 
characteristic plots. They evaluated its performance on 41 targets mostly from Directory of Useful Decoys 
(DUD) and obtained best results with kinases. The strategy worked well with the homology model and also 
succeeded when few structures were available as the training set. Virtual screening was performed against 1125 
compounds for two targets namely EGFR and CAMKII wherein three out of the 25 hit compounds showed good 
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inhibitory activity in vitro. In another report by the above group [31] the support vector regression method was 
applied for rank ordering and virtual screening of chemical libraries using community structure-activity resource 
(CSAR) datasets. Here, two new scoring functions were developed based on the knowledge of pair-wise 
potential and physiochemical properties. These scoring functions outperformed the well-established seven 
scoring functions namely Glide, VINA, Gold score, Dock, Chemscore, PMF and X score. Li et al.[31] 
developed a new function SVR_KBD employing a target specific strategy and the enrichment results were 
found comparable to their previously reported SVM-SP scoring function. 
 Waaserman and Bajorath [32]  have discussed at length various SVM-based target selective searching 
strategies for virtual screening. They have elucidated a superior  approach  in terms of enrichment factor as the 
SVM is trained on the data comprising more than two different classes viz., selective, promiscuously active and 
non-active compared to the commonly employed binary classification approach. Further, they present a 
modified preference ranking strategy leading to higher recall of selective compounds. Combinatorial support 
vector machines have been used as virtual screening tools [33] for searching dual-inhibitors of 11 combinations 
of 9 anticancer kinase targets (EGFR, VEGFR, PDGFR, Src, FGFR, Lck, CDK1, CDK2, GSK3). In this study, 
the C-SVM was found either comparable or slightly better than the other conventional method such as Surflex, 
Dock, Blaster, KNN and PNN. Plewczynski  et al. [34] performed an exclusive target-specific supervised SVM 
analysis for compounds retrieved from MDDR database related to five targets including cyclooxygenase-2, 
dihydrofolate reductase, thrombin, HIV-reverse transcriptase and antagonists of the estrogen receptor. The SVM 
model was based on only two dimensional topological descriptors related to atom pairs. The sensitivity and 
classification for all the protein targets were 80% and 100%, respectively. The literature is replete with more 
examples of successful application of SVM with both ligand and target based approaches. Table 1 shows a few 
representative ligands and their corresponding targets; needless to say that SVM modeling has comprehensively 
mapped chemical diversity and target space in virtual screening. 
 
Table 1: Representative examples of targets and ligands covered by SVM obtained from recent literature 
 
Sl No 
 
Targets 
 
2D structure of selected molecules 
 
Reference 
 
1 D3 dopamine receptor BP987( a partial agonist) 
 
 
 
Byvatov et al., 
[19 ] 
2 Ȗ secretase 
 
Xue-Gang et al., 
[43 ] 
3 EGFR and CamKII 
 
Li et al., [30 ] 
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4 Factor Xa 
 
Li  et al., [31 ] 
5 Muscarinic M1 
                    
Ma X H et al., 
[26] 
6 NMDA 
 
Ma X H et al.,  
[26 ] 
7 Thrombin 
 
Ma X H et al., 
 [26 ] 
8 HIV protease 
 
Ma X H et al.,  
[26 ] 
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9 Cephalosporin 
 
Ma X H et al., 
 [26 ] 
10 Renin 
 
Ma X H et al., [26 
] 
11 HDAC  
 
Tropsha , [ 45 ] 
12 AbL 
 
Liu et al., [ 44 ] 
13 mGluR1 
 
Mballo and 
Makarenkov [42] 
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14 PXR 
 
Plewczynski et al. 
[51] 
 
 
1.5 Feature based library selection 
 Although machine learning methods including the SVM yield good classification/regression results 
they are considered as "black-box" since the form and  parameters of the developed model cannot be interpreted 
meaningfully to gain an insight into the classification/ regression process. In the context of virtual screening, for 
example, the influence of individual molecular feature on the classification performance is not easily 
discernable. An interesting attempt to circumvent this drawback was made by Byvatov and Schneider [35]  who 
reported an SVM based algorithm for feature-based selection method for libraries of enzyme inhibitors towards 
a better understanding of the protein-ligand interactions. The study included a comparison with the classical 
model-independent Kolmogorov-Smirnov (KS)-based feature selection and it was found that the SVM is faster 
than the KS-based classifiers. This algorithm established the SVM as more intelligent, comprehensible and no 
longer a complete black box. 
 
1.6 Comparison of SVM with other virtual screening methods 
 A number of researchers have used SVM along with other commonly utilized machine learning 
methods  in the arena of virtual screening and the comparative results of some of these studies are briefly 
discussed here. An SVM in combination with docking studies produced better results for virtual screening 
experiments as observed by Li and co-workers [36] who identified a novel series of benzimidazole derivatives 
for EGFR, VEGFR and PDGFR kinases.  Similar results have been reported by Xie et al. [37] who discovered 
new and potent inhibitors of c-Met, a membrane receptor required for embryonic development and wound 
healing. The SVM results when supplemented with docking results led to higher number of hits and enrichment 
of actives in the dataset. Some of the SVM predicted actives were also validated experimentally in assays. Ren 
et al. [38] used a hierarchical methodology encompassing three virtual screening techniques viz.  SVM, 
pharmacophore modeling and docking in succession to predict potent inhibitors for Pim-1. These techniques 
were used to screen a large number of databases including Pubchem, Specs and Enamine and finally fifteen hits 
showing nanomolar activity were obtained. Luan and co-workers [39] used this strategy of combining SVM and 
molecular docking for discovering 9-amino acridine scaffolds as multi-target inhibitors for VEGFR-2 and Src 
Kinase and confirmed the results experimentally. 
 Apart from biological activity, toxicity of drugs is another major concern for pharma companies and 
relatively few accurate prediction methods are available. Kumar et al. [40]  used SVM methods to correctly 
estimate the genotoxicity levels of compounds in their training set. They studied in depth the effect of training 
set size and noise levels on the performance of SVM analyzing genotoxic and nongenotoxic compounds from 
large virtual screening libraries. The predictions made by the SVM model were on par with those made by 
TOPKAT- a commercial toxicity prediction tool by Accelerys. In another study [41], SVM in combination with 
pharmacophore modeling yielded good results for the development of glutamate non-competitive antagonists of 
mGluR1, a target implicated in nervous disorders. As the X-ray-solved structure is not available, ligand based 
virtual screening is the only approach for this  target. Using MDDR data set it was shown that multi-step virtual 
screening approach involving both virtual screening techniques is superior to using each of them individually. 
Mballo and Makarenkov [42] made a comparative study of six known machine learning methods viz. binary 
decision trees, neural networks, SVM, linear discriminant analysis, k-nearest neighbours and partial least 
squares by analysing test assay from the McMaster University Data Mining and Docking Competition. They 
evaluated the methods on the basis of various parameters such as sensitivity, enrichment factor and number of 
false positive and negatives. Finally, they came up with a variable selection procedure and applied it to the 
polynomial SVM.  Yang and co-workers [43] used random forest (RF) and SVM learning techniques to design 
inhibitors for gamma secretase, an important target for Alzheimer's disease. They observed that the RF model 
marginally outperformed the SVM method. Virtual screening using the model resulted in three hits in the ZINC 
database. AB1 is an important target for cancer therapy and considerable efforts have been made for developing 
inhibitors using insilico methods such as docking and pharmacophore modeling. Liu et al. [44] found SVM 
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approach better than the above mentioned techniques for identifying ABl inhibitors as it led to lower false hit 
rates and enabled searching of huge libraries. Tropsha et al. [45] used a combined Quantitative Structure 
Activity Relationship -Virtual Screening (QSAR-VS) approach involving kNN and SVM to develop human 
histone deacetylase HDAC inhibitors. Highly predictive models with good r2 vales were obtained and were 
rigorously cross-validated on external datasets. The model gave forty five unique hits while searching a huge in-
house database. In another comparative study by Bajorath and co-workers [46] the ranking provided by 
involving SVM proved to be far superior than the ones provided by nearest neighbour and centroid similarity 
search methods even when a smaller data set was used for training. The explanation given was that during the 
learning phase SVM uses information about database molecules, in addition to known active compounds. In a 
systematic study, Byvatov and co-workers [47] compared ANN and SVM methods as binary classifiers for 
discriminating drugs from non-drugs. They used three sets of descriptors viz. 120 Ghose-Crippen fragments, a 
wide range of 180 descriptors from the Molecular Operating Environment (MOE) package, and 225 topological 
pharmacophore (CATS) descriptors.  In general, SVM performed marginally better than the ANN with 
minimum error regardless of the choice of descriptors. However, the authors concluded that the two 
methodologies are complementary to each other as the results were similar but not identical. Melagraki et al. 
[48] did extensive work on developing inhibitors for MCH1 receptor by using a number of ligand based virtual 
screening techniques in tandem. First, a linear QSAR model was developed using multiple regression method 
following which the most suitable input variables were selected using the Elimination Selection-Stepwise 
Regression (ES-SWR) method. Finally, SVM was used to categorize the molecules into actives and non-actives. 
A number of efforts were expended to select the optimum scaffold and the activities of the predicted actives by 
SVM were estimated by using the MLRS model. Jorgenson group at University of Copenhagen developed many 
insilico models based on different classification methods such as binary QSAR, kNN, SVM, decision tree etc. 
for developing inhibitors for P450 1A2, an important enzyme in drug metabolism. Here, SVM, kNN and 
random forest methods were found to be the best methods delivering models with high prediction accuracy with 
a Mathews correlation coefficient of 0.5 [49]. Similar results were obtained by Khandelwal et al. [50] in their 
work on predicting pregnane X receptor activators using machine learning methods coupled with docking 
protocol. They observed that docking combined with regression yielded inferior results when compared with 
SVM and RF methods. Plewczynski et al. [51] have conducted extensive studies to assess a host of machine 
learning techniques such as SVM, random forest, ANN, k-nearest neighbour (kNN) classification with genetic-
algorithm-optimized feature selection, trend vectors, naive Bayesian classification, and decision tree, for their 
capacity to recognize ligands from a large data collection of molecules. Interestingly, they obtained varying 
results from the stated methods; while some were good in retrieving actives, others yielded high enrichment 
scores. However, all the methods could correctly predict the recently reported ligands. It was concluded that no 
single method can be the most consistent one; rather a combination of methods is essential for better results in 
virtual screening.  
 A case study: SVM based binary classification of molecules for their potential as anticancer agents 
A number of molecules tested as anticancer lead compounds against the human breast cancer cell line MCF-7 
were downloaded from Pubchem bioassay and NCI database and used for building an SVM based classifier. A 
dataset of 54 molecules containing actives and in-actives was constructed and split into training set (41 
molecules) and test set (13 molecules) (see Figure 5). 
 
 
Fig.5: 2D structure of some diverse molecules used in training and test set 
 The objective of the study was to build a classifier using SVM to discriminate inactives from actives 
for the given cancer cell line data. The molecules were washed, energy minimized and 186 descriptors were 
computed using MOE [52]. They include topological, shape and connectivity based descriptors. The descriptors 
were pruned using the QSAR contingency module in MOE and 20 descriptors mainly the Lipinski RO5 and 
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BCUT descriptors closely encoding the activity were selected.  RapidMiner 5.1 an open source data-mining 
software tool was used to generate the SVM classifier model [53]. The objective of the classification was to 
categorize a given molecule into “active” or “inactive” depending upon the descriptors encoding the activity. 
This is a supervised classification task where an example data containing each molecule’s descriptors (model 
inputs) and its class (active or inactive) defining model output are available. The RapidMiner consists of various 
types of SVM modules for performing supervised classification (clustering). Among these, the Support Vector 
Machine -Evolutionary (SVME) [54] yielded best classification results. The SVME uses an evolutionary 
algorithm (ES) for solving the dual optimization problem of an SVM. On many datasets, SVME performs as fast 
and accurate as the usual SVM implementations. Additionally, it is also capable of learning with Kernels which 
are not positive semi-definite. 
 The parameter values used in conducting the above stated classification are: (i) kernel type: 
ANOVA, kernel gamma = 1.0, kernel degree = 3, C = 0.β5, ε = 0.1, maximum number of generations = 10,000, 
population size = 5, selection type: Tournament, and crossover probability = 1.0. The stated combination of 
SVME parameters yielded excellent classification results wherein all the molecules in both the training and test 
sets were classified with 100% accuracy (no false positives or false negatives). For a training set of 41 input-
output patterns, the SVME method identified 24 support vectors. An excellent classification accuracy of 100% 
in respect of the test set molecules indicates that the developed SVME model is capable of accurately 
generalizing the learned classification to new molecules. A detailed study comparing the classification results 
from a number of SVM and ANN based classifiers for other cell lines data is currently in progress. 
 
2. CONCLUSION 
 SVM based screening is flexible, fast and it significantly increases the speed and accuracy of prediction 
in virtual screening experiments. To some extent, these advantages are offset by limitations such as low hit rate 
and high number of false positives. Consequently, there exists a need to speed up SVM and kernel methods, 
which will surely benefit virtual screening efforts at large. As rightly pointed out by Schneider [55] it might be 
wise to try out several predictive methods in parallel for the right solution in virtual screening. To sum it up, a 
consensus approach would be ideal for the large disparate datasets generally available for computational biology 
studies.  
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